This application is designed to train Dr. John Halpern to be an independent investigator with special skills in assessing both neuropsychological effects and cultural aspects of substance abuse. Dr. Halpern is now completing a third-year postdoctoral fellowship in substance abuse research at the Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School-a nationally recognized major substance abuse research facility. Dr. Halpern has already published several peer-reviewed papers on substance abuse, most recently a critical review of studies of the long-term neuropsychological effects of hallucinogens-a class of drugs increasing in popularity among high school students and young adults, 1,2 yet still inadequately studied. Dr. Harrison G. Pope, Jr., the proposed mentor for this project, is a well-recognized substance abuse investigator with an established record of mentoring junior investigators. With Dr. Pope's guidance, Dr. Halpern has already obtained pilot data assessing neuropsychological performance in 42 Native Americans. Ten of these subjects are members of the Native American Church. The practitioners of this religion are virtually unique in North America in that they extensively ingest a hallucinogen, the peyote cactus, but typically use no other drugs. Thus, they offer a valuable opportunity to assess the long-term effects of hallucinogen use without the confounding effects of other substances. Dr. Halpern has also obtained pilot data on comparison groups of 11 Native Americans with past alcohol dependence and 21 Native American controls. Under Dr. Pope's mentorship, Dr. Halpern proposes to expand this work over the next four years to study an additional 210 Navajo subjects: 70 peyote users, 70 former alcohol users, and 70 controls. These data will provide information of major public health significance, both for the Native American population itself and for the population at large, regarding the long-term neuropsychological effects of hallucinogens and alcohol. Dr. Halpern will supplement this work with a full program of courses in the Harvard School of Public Health, leading to an MPH degree within the four years, and with continued didactic experience with Dr. Pope and other investigators at the Alcohol and Drug Abuse Research Center. This program will enable Dr. Halpern to become an experienced investigator, capable of designing and performing future studies independently.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23DA000494-01
Application #
6192852
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Grant, Steven J
Project Start
2000-09-01
Project End
2004-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
1
Fiscal Year
2000
Total Cost
$122,891
Indirect Cost
Name
Mc Lean Hospital (Belmont, MA)
Department
Type
DUNS #
City
Belmont
State
MA
Country
United States
Zip Code
02478
Sekine, Yoshimoto; Ouchi, Yasuomi; Sugihara, Genichi et al. (2008) Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28:5756-61
Halpern, John H; Sewell, R Andrew (2005) Hallucinogenic botanicals of America: a growing need for focused drug education and research. Life Sci 78:519-26
Halpern, John H; Sherwood, Andrea R; Hudson, James I et al. (2005) Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry 58:624-31
Halpern, John H (2004) Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 102:131-8
Halpern, John H; Pope Jr, Harrison G; Sherwood, Andrea R et al. (2004) Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75:135-47
Halpern, John H (2003) Hallucinogens: an update. Curr Psychiatry Rep 5:347-54
Halpern, John H; Sholar, Michelle B; Glowacki, Julie et al. (2003) Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab 88:1188-93
Halpern, John H; Pope Jr, Harrison G (2003) Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend 69:109-19
Mendelson, Jack H; Mello, Nancy K; Sholar, Michelle B et al. (2002) Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology 27:71-82